Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center">Statistics %</td><td class="align_center">Cells (18 mL bone marrow)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Hematopoietic stem cells (HSCs)</td><td class="align_center">0.32 ± 0.20</td><td class="align_center">712362.5 ± 493434.1</td></tr><tr><td class="align_left">Mesenchymal stem cells (MSCs)</td><td class="align_center">0.00051 ± 0.00014</td><td class="align_center">1183.75 ± 493.6</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The relative percentage of various BM cell populations.</div>

Gastroenterology Research and Practice

tab3

Table 3

Table 3: Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy 